BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26659003)

  • 1. microRNA and Bone Cancer.
    Nugent M
    Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
    Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
    Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
    Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
    Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells.
    Zhou X; Chen J; Xiao Q; Wang T; Yu Y; Li B; Shao G; Li Y; Zhang Z
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors.
    Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
    Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
    Sun B; Yang M; Li M; Wang F
    Biomed Pharmacother; 2015 Apr; 71():58-63. PubMed ID: 25960216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
    Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
    Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma.
    Yang G; Zhang P; Lv A; Liu Y; Wang G
    Exp Mol Pathol; 2016 Feb; 100(1):160-6. PubMed ID: 26708425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory role of microRNA184 in osteosarcoma cells.
    Yin GR; Wang Q; Zhang XB; Wang SJ
    Genet Mol Res; 2015 Nov; 14(4):14246-52. PubMed ID: 26600482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
    Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
    Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin.
    Xu WG; Shang YL; Cong XR; Bian X; Yuan Z
    Int J Oncol; 2014 Nov; 45(5):2024-32. PubMed ID: 25190111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Palmini G; Marini F; Brandi ML
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
    Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT
    Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
    Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion.
    Karnuth B; Dedy N; Spieker T; Lawlor ER; Gattenlöhner S; Ranft A; Dirksen U; Jürgens H; Bräuninger A
    PLoS One; 2014; 9(3):e93067. PubMed ID: 24667836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential Ewing's sarcoma and osteosarcoma.
    Sharma V; Crawford AH; Evans J; Collins MH
    J Pediatr Orthop B; 2008 Nov; 17(6):333-7. PubMed ID: 18841070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.